A polymorphism in CALHM1 is associated with temporal lobe epilepsy.

Area of Science:

• Neurogenetics
• Epilepsy Pathophysiology

Background:

• The calcium homeostasis modulator 1 (CALHM1) gene is implicated in calcium homeostasis and amyloid β (Aβ) levels.
• Both calcium homeostasis and elevated Aβ are linked to epileptic seizures in the hippocampus, suggesting CALHM1's potential role in temporal lobe epilepsy (TLE).

Purpose of the Study:

• To investigate the genetic association between CALHM1 single-nucleotide polymorphisms (SNPs) and TLE.
• To determine if specific CALHM1 variants contribute to TLE susceptibility.

Main Methods:

• Genotyping of five CALHM1 SNPs using polymerase chain reaction restriction fragment length polymorphism.
• Analysis of 560 TLE patients and 401 healthy controls.
• Haplotype analysis considering apolipoprotein E ε4 status.

Main Results:

• A significant positive association was found between the CALHM1 SNP rs11191692 and TLE (OR=1.35, corrected P=0.015).
• The rs11191692-A allele was more frequent in TLE patients (32.4%) than controls (26.2%).
• No association was found between rs2986017 and TLE. Haplotype analysis supported the association of rs11191692 with TLE, independent of APOE ε4.

Conclusions:

• The study provides the first evidence linking the CALHM1 gene, specifically SNP rs11191692, to an increased susceptibility to temporal lobe epilepsy.
• This finding highlights CALHM1 as a potential genetic factor in TLE pathogenesis.